Lilly in India
Lilly operates in India through two business entities.
Since its inception in India in 1993, Eli Lilly and Company (India) Pvt. Ltd. has been committed to developing and marketing pharmaceutical products to treat diabetes, gastric cancer, lung cancer, osteoporosis, rheumatoid arthritis, men's health and growth-hormone deficiency. Lilly India affiliate also comprises operations in neighboring countries of Nepal, Bangladesh and Sri Lanka.
Lilly Capability Center India:
Lilly opened the Lilly Capability Center India (LCCI) in Bangalore in January 2016. This center allows Lilly to take advantage of unique drug development capabilities found in India.
Bangalore has been strategically chosen as a location for this center due to its concentration of research and development, electronics and software production companies.